Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

1-25 of 84 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3 Next ...

Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies.
Hahn WO, Parks KR, Shen M, Ozorowski G, Janes H, Ballweber-Fleming L, Woodward Davis AS, Duplessis C, Tomai M, Dey AK, Sagawa ZK, De Rosa SC, Seese A, Kallur Siddaramaiah L, Stamatatos L, Lee WH, Sewall LM, Karlinsey D, Turner HL, [...] McElrath MJ
J Exp Med, 221(10):e20240604, 05 Sep 2024
Cited by: 1 article | PMID: 39235529
Add to export list
HIV BG505 SOSIP.664 trimer with 3M-052-AF/alum induces human autologous tier-2 neutralizing antibodies
Hahn WO, Parks KR, Shen M, Ozorowski G, Janes H, Ballweber-Fleming L, Woodward Davis AS, Duplessis C, Tomai M, Dey AK, Sagawa ZK, De Rosa SC, Seese A, Siddaramaiah LK, Stamatatos L, Lee W, Sewall LM, Karlinsey D, Turner HL, [...] McElrath MJ
medRxiv, 09 May 2024
Cited by: 0 articles | PPR: PPR850962
Add to export list Preprint
Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo.
Hansen L, McMahon M, Turner HL, Zhu X, Turner JS, Ozorowski G, Stadlbauer D, Vahokoski J, Schmitz AJ, Rizk AA, Alsoussi WB, Strohmeier S, Yu W, Choreño-Parra JA, Jiménez-Alvarez L, Cruz-Lagunas A, Zúñiga J, Mudd PA, Cox RJ, [...] Krammer F
Immunity, 56(8):1927-1938.e8, 27 Jul 2023
Cited by: 8 articles | PMID: 37506693 | PMCID: PMC10529248
Add to export list Free full text in Europe PMC
Protocol for analyzing antibody responses to glycoprotein antigens using electron-microscopy-based polyclonal epitope mapping.
Turner HL, Jackson AM, Richey ST, Sewall LM, Antanasijevic A, Hangartner L, Ward AB
STAR Protoc, 4(3):102476, 28 Jul 2023
Cited by: 3 articles | PMID: 37516970 | PMCID: PMC10400963
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulins.
Misson Mindrebo L, Liu H, Ozorowski G, Tran Q, Woehl J, Khalek I, Smith JM, Barman S, Zhao F, Keating C, Limbo O, Verma M, Liu J, Stanfield RL, Zhu X, Turner HL, Sok D, Huang PS, Burton DR, [...] Jardine JG
Proc Natl Acad Sci U S A, 120(24):e2216612120, 05 Jun 2023
Cited by: 11 articles | PMID: 37276407 | PMCID: PMC10268213
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants.
Changrob S, Halfmann PJ, Liu H, Torres JL, McGrath JJC, Ozorowski G, Li L, Wilbanks GD, Kuroda M, Maemura T, Huang M, Zheng NY, Turner HL, Erickson SA, Fu Y, Yasuhara A, Singh G, Monahan B, Mauldin J, [...] Wilson PC
J Clin Invest, 133(8):e166844, 17 Apr 2023
Cited by: 7 articles | PMID: 36862518 | PMCID: PMC10104900
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody to antigenically distinct omicron SARS-CoV-2 subvariants
Changrob S, Halfmann PJ, Liu H, Torres JL, McGrath JJ, Ozorowski G, Li L, Kuroda M, Maemura T, Huang M, Wilbanks GD, Zheng N, Turner HL, Erickson SA, Fu Y, Singh G, Krammer F, Sather DN, Ward AB, [...] Wilson PC
bioRxiv, 01 Nov 2022
Cited by: 0 articles | PPR: PPR565115
Add to export list Preprint
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer.
van Schooten J, Schorcht A, Farokhi E, Umotoy JC, Gao H, van den Kerkhof TLGM, Dorning J, Rijkhold Meesters TG, van der Woude P, Burger JA, Bijl T, Ghalaiyini R, Torrents de la Peña A, Turner HL, Labranche CC, Stanfield RL, Sok D, Schuitemaker H, Montefiori DC, [...] van Gils MJ
PLoS Pathog, 18(11):e1010945, 17 Nov 2022
Cited by: 1 article | PMID: 36395347 | PMCID: PMC9714913
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site.
Stadlbauer D, McMahon M, Turner HL, Zhu X, Wan H, Carreño JM, O'Dell G, Strohmeier S, Khalil Z, Luksza M, van Bakel H, Simon V, Ellebedy AH, Wilson IA, Ward AB, Krammer F
Nat Commun, 13(1):7864, 21 Dec 2022
Cited by: 2 articles | PMID: 36543789 | PMCID: PMC9772378
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways.
Zhao F, Keating C, Ozorowski G, Shaabani N, Francino-Urdaniz IM, Barman S, Limbo O, Burns A, Zhou P, Ricciardi MJ, Woehl J, Tran Q, Turner HL, Peng L, Huang D, Nemazee D, Andrabi R, Sok D, Teijaro JR, [...] Jardine JG
iScience, 25(9):104914, 11 Aug 2022
Cited by: 4 articles | PMID: 35971553 | PMCID: PMC9367177
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein.
van Schooten J, Farokhi E, Schorcht A, van den Kerkhof TLGM, Gao H, van der Woude P, Burger JA, Meesters TGR, Bijl T, Ghalaiyini R, Turner HL, Dorning J, van Schaik BDC, van Kampen AHC, Labranche CC, Stanfield RL, Sok D, Montefiori DC, Burton DR, [...] van Gils MJ
Nat Commun, 13(1):4515, 03 Aug 2022
Cited by: 8 articles | PMID: 35922441 | PMCID: PMC9349188
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape
Zhao F, Keating C, Ozorowski G, Shaabani N, Francino-Urdaniz IM, Barman S, Limbo O, Burns A, Zhou P, Ricciardi MJ, Woehl J, Tran Q, Turner HL, Peng L, Huang D, Nemazee D, Andrabi R, Sok D, Teijaro JR, [...] Jardine JG
bioRxiv, 07 Jan 2022
Cited by: 0 articles | PPR: PPR440453
Add to export list Preprint
Human antibody recognition of H7N9 influenza virus HA following natural infection.
Gilchuk IM, Bangaru S, Kose N, Bombardi RG, Trivette A, Li S, Turner HL, Carnahan RH, Ward AB, Crowe JE
JCI Insight, 6(19):e152403, 08 Oct 2021
Cited by: 2 articles | PMID: 34437301 | PMCID: PMC8525637
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface.
Zost SJ, Dong J, Gilchuk IM, Gilchuk P, Thornburg NJ, Bangaru S, Kose N, Finn JA, Bombardi R, Soto C, Chen EC, Nargi RS, Sutton RE, Irving RP, Suryadevara N, Westover JB, Carnahan RH, Turner HL, Li S, [...] Crowe JE
J Clin Invest, 131(15):146791, 01 Aug 2021
Cited by: 20 articles | PMID: 34156974 | PMCID: PMC8321569
Add to export list Free full text in Europe PMC
Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization.
Turner HL, Andrabi R, Cottrell CA, Richey ST, Song G, Callaghan S, Anzanello F, Moyer TJ, Abraham W, Melo M, Silva M, Scaringi N, Rakasz EG, Sattentau QJ, Irvine DJ, Burton DR, Ward AB
Sci Adv, 7(31):eabh2791, 28 Jul 2021
Cited by: 32 articles | PMID: 34321200 | PMCID: PMC8318364
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface
Zost SJ, Dong J, Gilchuk I, Gilchuk P, Thornburg NJ, Bangaru S, Kose N, Finn JA, Bombardi R, Soto C, Nargi R, Irving RP, Suryadevara N, Westover JB, Carnahan RH, Turner HL, Li S, Ward AB, Crowe JE
bioRxiv, 03 Jan 2021
Cited by: 0 articles | PPR: PPR260695
Add to export list Preprint
Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection.
Brouwer PJM, Brinkkemper M, Maisonnasse P, Dereuddre-Bosquet N, Grobben M, Claireaux M, de Gast M, Marlin R, Chesnais V, Diry S, Allen JD, Watanabe Y, Giezen JM, Kerster G, Turner HL, van der Straten K, van der Linden CA, Aldon Y, Naninck T, [...] Sanders RW
Cell, 184(5):1188-1200.e19, 26 Jan 2021
Cited by: 116 articles | PMID: 33577765 | PMCID: PMC7834972
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Prominent Neutralizing Antibody Response Targeting the Ebolavirus Glycoprotein Subunit Interface Elicited by Immunization.
Wang Y, Howell KA, Brannan J, Agans KN, Turner HL, Wirchnianski AS, Kailasan S, Fusco M, Galkin A, Chiang CI, Zhao X, Saphire EO, Chandran K, Ward AB, Dye JM, Aman MJ, Geisbert TW, Li Y
J Virol, 95(8):JVI.01907-20, 03 Feb 2021
Cited by: 5 articles | PMID: 33536172 | PMCID: PMC8103683
Add to export list Free full text in Europe PMC
Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes.
Freyn AW, Han J, Guthmiller JJ, Bailey MJ, Neu K, Turner HL, Rosado VC, Chromikova V, Huang M, Strohmeier S, Liu STH, Simon V, Krammer F, Ward AB, Palese P, Wilson PC, Nachbagauer R
Proc Natl Acad Sci U S A, 118(8):e2018102118, 01 Feb 2021
Cited by: 7 articles | PMID: 33593910 | PMCID: PMC7923359
Add to export list Free full text in Europe PMC
Polyclonal epitope mapping reveals temporal dynamics and diversity of human antibody responses to H5N1 vaccination.
Han J, Schmitz AJ, Richey ST, Dai YN, Turner HL, Mohammed BM, Fremont DH, Ellebedy AH, Ward AB
Cell Rep, 34(4):108682, 01 Jan 2021
Cited by: 29 articles | PMID: 33503432 | PMCID: PMC7888560
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody.
Wu NC, Yuan M, Bangaru S, Huang D, Zhu X, Lee CD, Turner HL, Peng L, Yang L, Burton DR, Nemazee D, Ward AB, Wilson IA
PLoS Pathog, 16(12):e1009089, 04 Dec 2020
Cited by: 43 articles | PMID: 33275640 | PMCID: PMC7744049
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.
Bangaru S, Ozorowski G, Turner HL, Antanasijevic A, Huang D, Wang X, Torres JL, Diedrich JK, Tian JH, Portnoff AD, Patel N, Massare MJ, Yates JR, Nemazee D, Paulson JC, Glenn G, Smith G, Ward AB
Science, 370(6520):1089-1094, 20 Oct 2020
Cited by: 215 articles | PMID: 33082295 | PMCID: PMC7857404
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization
Turner HL, Andrabi R, Cottrell CA, Richey ST, Song G, Callaghan S, Anzanello F, Moyer TJ, Abraham W, Melo M, Silva M, Scaringi N, Rakasz EG, Sattentau Q, Irvine DJ, Burton DR, Ward AB
bioRxiv, 17 Feb 2021
Cited by: 0 articles | PPR: PPR284236
Add to export list Preprint
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins.
Bouwman KM, Tomris I, Turner HL, van der Woude R, Shamorkina TM, Bosman GP, Rockx B, Herfst S, Snijder J, Haagmans BL, Ward AB, Boons GJ, de Vries RP
PLoS Pathog, 17(2):e1009282, 08 Feb 2021
Cited by: 26 articles | PMID: 33556147 | PMCID: PMC7895411
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody
Wu NC, Yuan M, Bangaru S, Huang D, Zhu X, Lee CD, Turner HL, Peng L, Yang L, Nemazee D, Ward AB, Wilson IA
bioRxiv, 21 Sep 2020
Cited by: 0 articles | PPR: PPR217091
Add to export list Preprint
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 84 results

1 2 3 Next ...

Search life-sciences literature (45,104,145 articles, preprints and more)

Search results

Use of 3M-052-AF with Alum adjuvant in HIV trimer vaccine induces human autologous neutralizing antibodies.

HIV BG505 SOSIP.664 trimer with 3M-052-AF/alum induces human autologous tier-2 neutralizing antibodies

Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo.

Protocol for analyzing antibody responses to glycoprotein antigens using electron-microscopy-based polyclonal epitope mapping.

Fully synthetic platform to rapidly generate tetravalent bispecific nanobody-based immunoglobulins.

Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants.

Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody to antigenically distinct omicron SARS-CoV-2 subvariants

Complementary antibody lineages achieve neutralization breadth in an HIV-1 infected elite neutralizer.

Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site.

Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape pathways.

Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein.

Engineering SARS-CoV-2 neutralizing antibodies for increased potency and reduced viral escape

Human antibody recognition of H7N9 influenza virus HA following natural infection.

Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface.

Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization.

Canonical features of human antibodies recognizing the influenza hemagglutinin trimer interface

Two-component spike nanoparticle vaccine protects macaques from SARS-CoV-2 infection.

Prominent Neutralizing Antibody Response Targeting the Ebolavirus Glycoprotein Subunit Interface Elicited by Immunization.

Influenza hemagglutinin-specific IgA Fc-effector functionality is restricted to stalk epitopes.

Polyclonal epitope mapping reveals temporal dynamics and diversity of human antibody responses to H5N1 vaccination.

A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody.

Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.

Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization

Multimerization- and glycosylation-dependent receptor binding of SARS-CoV-2 spike proteins.

A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibody

Partnerships & funding